The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
NeoGenomics Inc. | COM NEW | 64049M209 | 91,395 | 2,023,355 | SH | SOLE | 2,023,355 | 0 | 0 | ||
Horizon Therapeutics Public Limited Company | SHS | G46188101 | 51,200 | 546,775 | SH | SOLE | 546,775 | 0 | 0 | ||
Vericel Corporation | COM | 92346J108 | 28,322 | 539,475 | SH | SOLE | 539,475 | 0 | 0 | ||
Five9, Inc. | COM | 338307101 | 16,785 | 91,527 | SH | SOLE | 91,527 | 0 | 0 | ||
ISHARES TR | CORE 1 5 YR USD | 46432F859 | 105 | 2,050 | SH | SOLE | 2,050 | 0 | 0 | ||
ISHARES TR | CORE S&P500 ETF | 464287200 | 126 | 292 | SH | SOLE | 292 | 0 | 0 | ||
ISHARES TR | CORE MSCI EAFE | 46432F842 | 25,462 | 340,128 | SH | SOLE | 340,128 | 0 | 0 | ||
ISHARES TR | CORE INTL AGGR | 46435G672 | 43 | 783 | SH | SOLE | 783 | 0 | 0 | ||
ISHARES TR | CR 5 10 YR ETF | 46435G417 | 39 | 764 | SH | SOLE | 764 | 0 | 0 | ||
ISHARES TR | CORE S&P MCP ETF | 464287507 | 40 | 147 | SH | SOLE | 147 | 0 | 0 | ||
ISHARES TR | CORE MSCI EMKT | 46434G103 | 18,206 | 271,766 | SH | SOLE | 271,766 | 0 | 0 | ||
ISHARES TR | CORE S&P SCP ETF | 464287804 | 23 | 207 | SH | SOLE | 207 | 0 | 0 | ||
JAMF HOLDING CORP | COM | 47074L105 | 9,851 | 293,460 | SH | SOLE | 293,460 | 0 | 0 |